Home › Funds › BOCHK Asset Management Ltd › MRNA

BOCHK Asset Management Ltd position in MRNA

MODERNA INC · Health Care

BOCHK Asset Management Ltd reported holding 40,300 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$7.8M, representing 1.09% of its reported portfolio and ranking #25 among its reported holdings. BOCHK Asset Management Ltd first reported this position in Q3 2026.

Latest position (Q3 2026)40.30K sh
Reported value held$7.76M
Portfolio Weight1.09%
First reportedQ3 2026
Last changeNew
Updated2026-10-30

Last updated: 2026-10-30 · Source: SEC EDGAR Form 13F-HR

How BOCHK Asset Management Ltd's MRNA position evolved

BOCHK Asset Management Ltd first disclosed a stake in MRNA in Q3 2026 at 40,300 shares (US$7.8M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 40.30K $7.76M New

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 37 other funds we track also report a position in MRNA — the largest reported positions include Baillie Gifford & Co (US$1.28B), Theleme Partners LLP (US$564.3M), BANQUE PICTET & CIE SA (US$414.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has BOCHK Asset Management Ltd held MRNA?

BOCHK Asset Management Ltd has disclosed MRNA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is BOCHK Asset Management Ltd's current position in MRNA?

As of Q3 2026, BOCHK Asset Management Ltd holds 40.30K shares of MRNA (MODERNA INC), valued at $7.76M, representing 1.09% of its reported portfolio and ranking #25.

Has BOCHK Asset Management Ltd been buying or selling MRNA?

In the latest 13F filing (Q3 2026), BOCHK Asset Management Ltd newly opened its position in MRNA.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Baillie Gifford & Co, Theleme Partners LLP, BANQUE PICTET & CIE SA, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.